Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Pancreatic Cancer × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 28 Carcinoma, Hepatocellular 19 Small Cell Lung Carcinoma 14 Sarcoma 12 Carcinoma, Non-Small-Cell Lung 12 Ovarian Neoplasms 11 Colorectal Neoplasms 11 Breast Neoplasms 10 Nasopharyngeal Carcinoma 9 Esophageal Squamous Cell Carcinoma 9 Triple Negative Breast Neoplasms 8 Cholangiocarcinoma 8 Squamous Cell Carcinoma of Head and Neck 6 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Biliary Tract Neoplasms 5 Melanoma 4 Lung Neoplasms 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Solid Tumor 3 Recurrence 3 Pancreatic Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Glioma 3 Carcinoma, Adenoid Cystic 3 Neoplasms 2 Nasopharyngeal Neoplasms 2

Interventions

Gemcitabine 5 Taxes 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 nimotuzumab 1 irinotecan sucrosofate 1 envafolimab 1 endostar protein 1 cabiralizumab 1 apatinib 1 S 1 (combination) 1 Radiosurgery 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Immunotherapy 1 IMM-101 1 Fluorouracil 1 Endostatins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03662035 2018-09-19

ASPC

Changzhou No.2 People's Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡